Scale -


  • Revenue is 17825 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 14 %
  • Quarterly Revenue is 4917 Rs Cr; Continuous Growth over 3 Quarters
  • PBT is 742 Rs Cr; in Top Quartile
  • Quarterly Profit is 550 Rs Cr; in Top Quartile
  • Ebitda is 898 Rs Cr; Continuous Decline over 3 years
  • PAT is 557 Rs Cr; Continuous Decline over 3 years

Profitability -


  • Quarterly Profit margin is 10 %; in Top Quartile
  • PBDIT Margin is 5.03 %; Annual Decline is -19 %; Continuous Decline over 3 years
  • PAT Margin is 3.12 %; Annual Decline is -22 %; Continuous Decline over 3 years

Return -


  • Asset Turnover is 79 %; in Top Quartile; Continuous Decline over 3 years
  • ROA is 2.31 %; Annual Decline is -25 %; Continuous Decline over 3 years
  • ROCE is 10.2 %; Continuous Decline over 3 years
  • ROE is 7.35 %; Continuous Decline over 3 years

Efficiency -


  • Operating cash flow is 1873 Rs Cr; Annual Growth is 36 %; Continuous Growth over 3 years; 5 Year CAGR is 141 %
  • Current Ratio is 0.22; Continuous Growth over 3 years
  • Quick Ratio is 0.22; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 0; in Top Quartile

Solvancy -


  • Debt/Equity is 0.06; 5 Year CAGR is -22 %
  • Contingent Liabilities is 730 Rs Cr; Annual Growth is 79 %; Continuous Growth over 3 years; 5 Year CAGR is 65 %
  • Long term Debt is 470 Rs Cr; in Top Quartile
  • Total Debt is 470 Rs Cr; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 209 %; Annual Growth is 51 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is 336 %; Annual Growth is 58 %; Continuous Growth over 3 years
  • Other Expenses/Total Expenses is 88 %; in Bottom Quartile
  • Current Tax/PAT is 36 %; Continuous Growth over 3 years; in Top Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Star Health reports Normalised PAT of ?390 Crores in Q2 FY27, up 70% YoY, fifth successive quarter of underwriting profit improvement
Star Health and Allied Insurance Company Limited Q2 Normalised PAT ?390C, Up 70% YoY
Star Health STARHEALTH Q2 FY27 Results Newspaper Publication
Star Health to host analyst meeting in Mumbai on November 3
Earnings call transcript: Star Health posts stronger Q2 2026 turnaround By Investing.com
Star Health (NSE:STARHEALTH) Q2 FY27 Results: Normalised PAT ?390 Crores, GWP ?5,275 Crores
Star Health H1 FY27 slides: underwriting profit surges amid digital push
Star Health Q2: Net Profit Jumps 233% to ?265 Crore; Insurance Revenue Rises 15%
Star Health settles 22.5 lakh claims in H1 FY27; settlement ratio improves to 92.4%
Star Health wants mandated products kept out of Irdai’s expense cap
Vedanta Limited Posts Record Q2 FY27 Net Profit of Rs 6,202 Crore; Star Health Reports 232% Surge in Q2 Profit
Star Health and Allied Insurance: Q2 & H1 FY27 Earnings Surge 57%
Star Health: Board Approves Q2 FY27 Financial Results, Promoter Group Changes
Star Health: Files Integrated Financial Results for Q2 FY27
Star Health: Reports Q2 FY27 Unaudited Results; Reclassifies Promoter Group Entity
Star Health’s PAT Up 233% At Rs265 Cr
Star Health Brings 'Bishram Grih' and Face Scan Health Assessments to Durga Puja Pandals in Kolkata and Durgapur